Therapeutic monoclonal antibodies are proven and effective treatment options for various diseases, such as cancer, autoimmune disorders, and infectious disease. Opto Plasma B Discovery 2.0 on the Beacon system provides an automated workflow that decreases the time to obtain antigen-specific antibody sequences to less than 1 week. Download this App Note to learn how!